Joseph Jimenez, the chief executive of Novartis, is celebrating a triumph. The Food and Drug Administration approved Kymriah, a new treatment for kids with leukemia. But he's also taking heat from all sides over his decision to charge $475,000 for the treatment, and, in a major first, to negotiate deals that charge only patients who go into remission.
Christopher Plascencia won a promotion last month to personal banker at Wells Fargo & Co.; now he's worried the career advancement might become a hollow gain.
One third of businesses have failed to complete a modern slavery statement despite being required by law to do so, according to a report by the Chartered Institute of Procurement and Supply (CIPS).
Futurists extol the virtues of the gig economy - a world of contract workers who call their own hours and enjoy a degree of independence not available to full-timers. But there's a downside to that scenario as well.
Members of the European Parliament have called for a faster alert system and fines for states that fail to share food safety information following a tainted eggs scandal.